https://orcid.org/0000-0003-0255-6283
References
- Bekele, B. N., Shen, Y. (2005). A bayesian approach to jointly modeling toxicity and biomarker expression in a phase i/ii dose-finding trial. Biometrics 61(2):344–354.
- Bekele, B. N., Thall, P. F. (2004). Dose-finding based on multiple toxicities in a soft tissue sarcoma trial. Journal of the American Statistical Association 99(465):26–35. doi:10.1198/016214504000000043
- Braun, T. M., Thall, P. F., Nguyen, H., de Lima, M. (2007). Simultaneously optimizing dose and schedule of a new cytotoxic agent. Clinical Trials 4(2):113–124. PMID: 17456511. doi:10.1177/1740774507083569
- Dragalin, V., Fedorov, V. (2006). Adaptive designs for dose-finding based on efficacy-Ştoxicity response. 136:1800–1823. doi:10.1093/jn/136.2.343
- Ezzalfani, M., Zohar, S., Qin, R., Mandrekar, S. J., Deley, M.-C. L. (2013). Dose-finding designs using a novel quasi-continuous endpoint for multipleâĂĽ toxicities. Statistics in Medicine 32(16):2728–2746. doi:10.1002/sim.5737
- Fedorov, V., Wu, Y., Zhang, R. (2012). Optimal doseâĂŘfinding designs with correlated continuous and discrete responses. Statistics in Medicine 31(3):217–234. doi:10.1002/sim.4388
- Hornik, K., Leisch, F., Zeileis, A. (2003). Jags: A program for analysis of bayesian graphical models using gibbs sampling. In Proceedings of DSC, volume 2, 1, Vienna, Austria.
- Houede, N., Thall, P. F., Nguyen, H., Paoletti, X., Kramar, A. (2010). Utility-based optimization of combination therapy using ordinal toxicity and efficacy in phase i/ii trials. Biometrics 66(2):532–540. doi:10.1111/j.1541-0420.2009.01302.x
- Lee, S. M., Hershman, D. L., Martin, P., Leonard, J. P., Cheung, Y. K. (2012). Toxicity burden score: A novel approach to summarize multiple toxic effects. Annals of Oncology 23(2):537–541. doi:10.1093/annonc/mdr146
- Legedza, A. T., Ibrahim, J. G. (2000). Longitudinal design for phase i clinical trials using the continual reassessment method. Controlled Clinical Trials 21(6):574–588. doi:10.1016/S0197-2456(00)00091-X
- R Core Team (2016). R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing.
- Thall, P. F., Cook, J. D. (2004). Dose-finding based on efficacyâĂŞtoxicity trade-offs. Biometrics 60(3):684–693. doi:10.1111/j.0006-341X.2004.00218.x
- Wang, C. Y., Wang, N., Wang, S. (2000). Regression analysis when covariates are regression parameters of a random effects model for observed longitudinal measurements. Biometrics 56(2):487–495. doi:10.1111/j.0006-341X.2000.00487.x
- Yin, J., Qin, R., Ezzalfani, M., Sargent, D. J., Mandrekar, S. J. (2017). A bayesian dose-finding design incorporating toxicity data from multiple treatment cycles. Statistics in Medicine 36(1):67–80. sim.7134. doi:10.1002/sim.v36.1